BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 29277732)

  • 1. Effects of curettage after shave biopsy of unexpected melanoma: A retrospective review.
    Yang YW; DiCaudo DJ
    J Am Acad Dermatol; 2018 May; 78(5):1000-1002. PubMed ID: 29277732
    [No Abstract]   [Full Text] [Related]  

  • 2. Think before you shave: Factors influencing choice of biopsy technique for invasive melanoma and effect on definitive management.
    de Menezes SL; Wolfe R; Kelly JW; Farrugia H; Mar VJ
    Australas J Dermatol; 2020 May; 61(2):134-139. PubMed ID: 31869446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shave and punch biopsy for skin lesions.
    Pickett H
    Am Fam Physician; 2011 Nov; 84(9):995-1002. PubMed ID: 22046939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Desmoplastic melanoma: a 12-year experience with sentinel lymph node biopsy.
    Broer PN; Walker ME; Goldberg C; Buonocore S; Braddock DT; Lazova R; Narayan D; Ariyan S
    Eur J Surg Oncol; 2013 Jul; 39(7):681-5. PubMed ID: 23522951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complication rates in sentinel lymph node biopsy for melanoma.
    Smith JR; Wilson AD
    J Plast Reconstr Aesthet Surg; 2016 Mar; 69(3):442. PubMed ID: 26715555
    [No Abstract]   [Full Text] [Related]  

  • 6. Surgical cost implications of the AJCC v8 staging system for melanoma and the melanoma in focus consensus statement.
    Thomson DR; King ICC; Cooper L; Odili J; Powell BWEM
    J Plast Reconstr Aesthet Surg; 2019 Oct; 72(10):1700-1738. PubMed ID: 31362864
    [No Abstract]   [Full Text] [Related]  

  • 7. Frequency of residual melanoma in wide local excision (WLE) specimens after complete excisional biopsy.
    Bolshinsky V; Lin MJ; Serpell J; Leung M; Wolfe R; McLean C; Kelly JW
    J Am Acad Dermatol; 2016 Jan; 74(1):102-7. PubMed ID: 26601566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A retrospective comparison between preoperative and postoperative Breslow depth in primary cutaneous melanoma: how preoperative shave biopsies affect surgical management.
    Saco M; Thigpen J
    J Drugs Dermatol; 2014 May; 13(5):531-6. PubMed ID: 24809875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defining the role of CD2 in disease progression and overall survival among patients with completely resected stage-II to -III cutaneous melanoma.
    Harcharik S; Bernardo S; Moskalenko M; Pan M; Sivendran M; Bell H; Hall LD; Castillo-Martín M; Fox K; Cordon-Cardo C; Chang R; Sivendran S; Phelps RG; Saenger Y
    J Am Acad Dermatol; 2014 Jun; 70(6):1036-44. PubMed ID: 24698703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sentinel lymph node biopsy for the T1 (thin) melanoma: is it necessary?
    Nahabedian MY; Tufaro AP; Manson PN
    Ann Plast Surg; 2003 Jun; 50(6):601-6. PubMed ID: 12783009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and pathologic factors associated with deep transection of biopsies of invasive melanoma.
    Woodcock JL; Eyre ZW; Stoddard GJ; Callis Duffin K; Bowen AR
    J Am Acad Dermatol; 2017 Oct; 77(4):766-768. PubMed ID: 28917460
    [No Abstract]   [Full Text] [Related]  

  • 12. Shave biopsy is a safe and accurate method for the initial evaluation of melanoma.
    Zager JS; Hochwald SN; Marzban SS; Francois R; Law KM; Davis AH; Messina JL; Vincek V; Mitchell C; Church A; Copeland EM; Sondak VK; Grobmyer SR
    J Am Coll Surg; 2011 Apr; 212(4):454-60; discussion 460-2. PubMed ID: 21463767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-center, single-operator, retrospective analysis of base transection rates in shave procedures for melanoma diagnosis.
    Pitney T; Muir DJ
    J Am Acad Dermatol; 2021 Mar; 84(3):861-862. PubMed ID: 33616070
    [No Abstract]   [Full Text] [Related]  

  • 14. Biopsy for malignant melanoma--are we following the guidelines?
    Tadiparthi S; Panchani S; Iqbal A
    Ann R Coll Surg Engl; 2008 May; 90(4):322-5. PubMed ID: 18492398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of shave biopsy on the management of patients with thin melanomas.
    Lowe M; Hill N; Page A; Chen S; Delman KA
    Am Surg; 2011 Aug; 77(8):1050-3. PubMed ID: 21944522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Skin melanoma].
    Lääkäriseuran S;
    Duodecim; 2005; 121(24):2725-39. PubMed ID: 16869061
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluating invasive cutaneous melanoma: is the initial biopsy representative of the final depth?
    Ng PC; Barzilai DA; Ismail SA; Averitte RL; Gilliam AC
    J Am Acad Dermatol; 2003 Mar; 48(3):420-4. PubMed ID: 12637923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Underuse of the Sentinel Lymph Node Biopsy for High-Risk Squamous Cell Carcinoma of the Skin.
    Ahadiat O; Higgins S; Kwon S; Wysong A
    JAMA Dermatol; 2018 Jan; 154(1):101. PubMed ID: 29141074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and experimental evaluation of a quantified depth shave biopsy device-Proof of concept.
    Gutwein LG; Davignon B; Katona T; Wade CL; Tholpady SS
    J Plast Reconstr Aesthet Surg; 2017 Jun; 70(6):855-857. PubMed ID: 28285009
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of biopsy type on outcomes in the treatment of primary cutaneous melanoma.
    Mills JK; White I; Diggs B; Fortino J; Vetto JT
    Am J Surg; 2013 May; 205(5):585-90; discussion 590. PubMed ID: 23592167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.